TheraRadar
← Back
Data updated: Jun 28, 2026

LEPU PHARM

Generics
Pharmaceuticals

LEPU PHARM is a generic drug manufacturer with 1 FDA-approved products.

2022
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

LEPU PHARM's Key Drugs

LEPU PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

LEPU PHARM's Recent FDA Approvals

New NDA/BLA approvals for LEPU PHARM over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

LEPU PHARM's Therapeutic Areas

Disease areas where LEPU PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

LEPU PHARM Pipeline Snapshot

Active clinical trials for LEPU PHARM across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling